Sign in

Sara Valpione 🌻

@saravalpione.bsky.social
780 followers 394 following 81 posts

Clinical Senior Lecturer, Clinician in Residence, Med Oncology Consultant at Univ. of Manchester & CRUK NBC & Christie; #ESMO UpperGI faculty, #EORTC UGI MRD. #Tcells, #liquid_biopsies, #nanomedicine, #immunotherapy.

PostsRepliesMedia
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 11/08/2026
Spatial and Multi-Omics Analysis of Human Breast Cancer Reveals the Spatiotemporal Dynamics of Basal Layer Disruption www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 11/08/2026
Epigenetic evolution of colorectal cancer and its microenvironment reveals new vulnerabilities www.biorxiv.org/content/10.64898/20…
032
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 11/08/2026
LncRNA-mediated organization of oncogenic chromatin state is a targetable vulnerability in leukemia www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
NEJM.org @nejm.org · 11/08/2026
A 60-year-old woman with stage II triple-negative breast cancer presented to the ED with a weeklong history of fevers, rigors, malaise, nonproductive cough, and nausea. Full case details and authors’ commentary: nej.md/4gcsyDH
A figure from the Clinical Problem-Solving article "Consumed with Inflammation" that shows CT of the chest, abdomen, and pelvis. A yellow arrow points to a fluid collection measuring 4 cm by 3 cm in the left axillary space where the patient had undergone her lumpectomy and axillary lymph-node biopsy.
011
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 11/08/2026
Hypoxia and epithelial to mesenchymal transition pathways are enriched in bladder tumor epithelium adjacent to tertiary lymphoid structures www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
Itai Yanai @itaiyanai.bsky.social · 11/08/2026
Night Science sessions are popping up everywhere! Contact me for support in setting one up in your area. Our NYC club has been going strong for nearly two years with so many amazing sessions!
061
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 11/08/2026
Multi-region whole-genome and transcriptomic profiling uncovers plastic, subclone-linked cell states in high-grade diffuse astrocytomas www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 11/08/2026
Concurrent AXL inhibition enhances RAS and ERK inhibitor efficacy in KRAS-mutant pancreatic and lung cancer www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
Vincent Zimmerman @zimmermanv66.bsky.social · 11/08/2026
041421369
Reposted by Sara Valpione 🌻
Joshua Shapiro @josh.shapiro.foo · 11/08/2026
We're hiring! The @cancerdatalab.bsky.social at @alexslemonade.bsky.social is looking for a Data Scientist to add to our team. We do a lot of things on our small Data Lab team, and we're looking for someone great to help up further our mission. www.ccdatalab.org/open-positio...
ccdatalab.org
Open Position - Data Scientist
178
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 11/08/2026
A compartment-adjustment framework reclassifies FOXC1 as a stromal-vascular readout in Luminal A breast cancer and recasts the basal-lineage "Centaur" signal as a tumour-population axis www.biorxiv.org/content/10.64898/20…
001
Reposted by Sara Valpione 🌻
American Association for Cancer Research (AACR) @theaacr.bsky.social · 10/08/2026
What are the drivers of cancer disparities? Learn more in the @AACR Cancer Disparities Progress Report: cancerprogressreport.aacr.org/disparities/...
022
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 22/07/2026
Topical Activatable Fluorescence Probes for Rapid Intraoperative Detection of Peritoneal Dissemination in High-Grade Serous Ovarian Carcinoma www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 22/07/2026
Whole transcriptome analysis reveals ELK3 as a key driver of metastasis through regulation of 3D migration and stemness in triple-negative breast cancer cells www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 22/07/2026
Circulating Immune Profiling Reveals Immune Signatures Associated with Disease Stage and Outcome in Endometrial Cancer www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
NEJM.org @nejm.org · 22/07/2026
Among cisplatin-eligible patients with muscle-invasive bladder cancer undergoing cystectomy, perioperative enfortumab vedotin–pembrolizumab led to significantly better event-free survival outcomes than cisplatin–gemcitabine. Full phase 3 KEYNOTE-B15/EV-304 trial results: nej.md/4wh8FB9
A graph from an Original Article published in the New England Journal of Medicine article titled "Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer." The graph shows event-free survival. The trial name, KEYNOTE-B15/EV-304, is in parentheses after the title. The NEJM identity sits at the bottom.
042
Reposted by Sara Valpione 🌻
Melanie Jackson @mjjaxn.bsky.social · 22/07/2026
The problem with digital books is that you can always find what you are looking for but you need to go to a bookstore to find what you weren't looking for. ~ Paul Krugman
642329400
Reposted by Sara Valpione 🌻
SFIGATTO @sfigatto.it · 23/07/2026
CORSO DI ADDESTRAMENTO PER GATTI
2657
Reposted by Sara Valpione 🌻
🎃Bushybritches🎃 @bushybritches.bsky.social · 22/07/2026
🤩🤩🤩 This is so cool! A possible new single dose treatment for colon cancer that also acts as an immunization from getting it again. It uses bacteria from tree frogs. Short video if you don’t wanna read the article. youtube.com/shorts/VGvuE... www.sciencedaily.com/releases/202...
sciencedaily.com
This frog bacterium wiped out cancer tumors in mice with a single dose
A naturally occurring bacterium from amphibian intestines completely eliminated colorectal tumors in mice with a single treatment by both attacking cancer cells and activating the immune system. The f...
3336241178
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 23/07/2026
A Novel Syngeneic Mouse Model to Study Immune Evasion in Head and Neck Squamous Cell Carcinoma www.biorxiv.org/content/10.64898/20…
021
Reposted by Sara Valpione 🌻
EACR - European Association for Cancer Research @helloeacr.bsky.social · 23/07/2026
Don't forget that the EACR-Worldwide Cancer Research Collaboration Fellowships are a new initiative this year, and you could be one of the first fellows! Application deadline: 03 September 2026 Apply here: eacr.org/collaboratio...
012
Reposted by Sara Valpione 🌻
The OncoAlert Network 🚨 @oncoalert.bsky.social · 23/07/2026
ADCs 💊 are already changing cancer treatment—but are we getting the next generation right? Antibody–drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation
011
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 23/07/2026
Genetic and Pharmacologic Targeting of Eya3 in Macrophages Drives Anti-Tumor Immunity in Triple-Negative Breast Cancer www.biorxiv.org/content/10.64898/20…
012
Reposted by Sara Valpione 🌻
NEJM.org @nejm.org · 23/07/2026
New in NEJM: Daraxonrasib in Metastatic Pancreatic Cancer (RASolute 302) Enfortumab Vedotin–Pembrolizumab in Bladder Cancer (KEYNOTE-B15/EV-304) Meningococcal B Vaccine for 𝘕. 𝘨𝘰𝘯𝘰𝘳𝘳𝘩𝘰𝘦𝘢𝘦 Infection (GoGoVax) Explore the issue: nej.md/current-issue
Cover page of NEJM.org dated July 23, 2026. It includes sections like Specialties, Topics, Multimedia, Current Issue, and Learning/CME. Featured content includes a Review Article on HIV treatment and an audio interview with Arnold Monto on studying vaccine effectiveness. The page also highlights a Quick Take video titled "Daraxonrasib in Metastatic Pancreatic Cancer" and an Images in Clinical Medicine article title "Koebner Phenomenon from Wet Cupping."
042
Reposted by Sara Valpione 🌻
British Society for Immunology @britsocimm.bsky.social · 23/07/2026
You don't have to wait for a course date to build your bioinformatics skills. Our self-paced bioinformatics courses are available wherever you're based, so you can start learning when you need to and progress at your own pace. Explore the courses: vist.ly/5c8wg
Graphic promoting self-paced bioinformatics courses with colorful pattern on the right.
032
Reposted by Sara Valpione 🌻
Mike Feigin 🥯 @mikefeigin.bsky.social · 23/07/2026
I really enjoyed Project Hail Mary overall. It’s not often that a molecular biologist is the good guy.
1162
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 23/07/2026
Macrophage-instructed GSDME couples glioblastoma cell-state plasticity with inflammatory cell death www.biorxiv.org/content/10.64898/20…
011
Reposted by Sara Valpione 🌻
Itai Yanai @itaiyanai.bsky.social · 23/07/2026
Going from a creative idea [..you ask..] what's the fastest way we could find out that it's completely wrong? .. that doesn't come naturally to a lot of people because they become attached to their ideas... you have to be able to have many ideas & most of them could be wrong. –@benlehner.bsky.social
193
Reposted by Sara Valpione 🌻
Elizabeth McKenna @elizsmckenna.bsky.social · 23/07/2026
Now online in Cancer Discovery @aacrjournals.bsky.social: Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors doi.org/10.1158/2159...
132
Reposted by Sara Valpione 🌻
Itai Yanai @itaiyanai.bsky.social · 23/07/2026
If you always stick to the field you were trained in, you could be denying yourself the chance of creating a new field.
2184
Reposted by Sara Valpione 🌻
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 22/07/2026
Ribonucleotide Reductase Inhibition Overcomes FLT3 Inhibitor Resistance in Acute Myeloid Leukemia www.biorxiv.org/content/10.64898/20…
021
Reposted by Sara Valpione 🌻
Barbara Marte @barbmarte.bsky.social · 22/07/2026
new out in Nature www.nature.com/articles/s41...
nature.com
Brown bullhead catfish melanoma represents a novel transmissible cancer - Nature
Whole-genome sequencing analysis of tumour and matched non-tumour host tissues of the brown bullhead catfish reveals a type of naturally occurring transmissible cancer.
021
Reposted by Sara Valpione 🌻
billkittle.bsky.social @billkittle.bsky.social · 22/07/2026
5860371524
Reposted by Sara Valpione 🌻
Barbara Marte @barbmarte.bsky.social · 22/07/2026
new our in Nature www.nature.com/articles/s41...
nature.com
Prior therapy defines mutation profiles in childhood cancer at relapse - Nature
Chemotherapy, particularly with platinum-based drugs, is associated with substantial, rapidly detectable mutagenesis in childhood cancers, tripling private signatures and doubling mutation burden, hig...
041
Reposted by Sara Valpione 🌻
Itai Yanai @itaiyanai.bsky.social · 22/07/2026
Day science is trying to design tests that would disprove a hypothesis – and night science is finding something that wasn't initially thought of. So basically wandering into the forest of the data and trying to figure out what's up. – Yana Bromberg, on the Night Science Podcast, Ep. 8
183
Reposted by Sara Valpione 🌻
Barbara Marte @barbmarte.bsky.social · 22/07/2026
new out in Nature www.nature.com/articles/s41...
nature.com
Tertiary lymphoid structures harbour stem-like tumour-specific T cells - Nature
Renal cell carcinoma tumours containing tertiary lymphoid structures (TLSs) are enriched for exhausted CD8+ T cells, including tumour-specific clonotypes with stem-like progenitor features and reduced...
022
Reposted by Sara Valpione 🌻
Elizabeth McKenna @elizsmckenna.bsky.social · 22/07/2026
Now online in Cancer Discovery @aacrjournals.bsky.social: LPL-Positive Endothelial Cells Control T-cell Homing in Liver Metastasis - by Xiaowen Zhang, Mahak Singhal, @hellmutaugustin.bsky.social, and colleagues doi.org/10.1158/2159... @dkfz.bsky.social @uniheidelberg.bsky.social
042
Reposted by Sara Valpione 🌻
Barbara Marte @barbmarte.bsky.social · 22/07/2026
new out in Nature www.nature.com/articles/s41...
nature.com
Genetic background sets the trajectory of experimental cancer evolution - Nature
Experimentally replaying tumour evolution in divergent mouse strains reveals the importance of interactions between genetic ancestry and acquired cancer-driving mutations in shaping the earliest stage...
02514
Reposted by Sara Valpione 🌻
UK Research and Innovation @ukri.org · 22/07/2026
"Stop whispering about picking winners." Dr Robert Sorrell, argues that UK research and development needs to be open about difficult choices, and that we must protect curiosity-driven science at the same time. More and to subscribe: ukri.substack.com/p/stop-whisp...
ukri.substack.com
"Stop whispering about picking winners": Dr Robert Sorrell on why UK R&D needs to be open about difficult choices
Dr Robert Sorrell sets out his tests for difficult R&D choices – and why we must protect curiosity-driven science and core skills at the same time
023
Reposted by Sara Valpione 🌻
Christie Library & Knowledge Services @christielibrary.bsky.social · 21/07/2026
youtu.be/G3qbHYl0pGw?...
youtu.be
Our new five-year strategy
YouTube video by UK Research and Innovation
011
Reposted by Sara Valpione 🌻
Manchester Cancer Research Centre @mcrcnews.bsky.social · 21/07/2026
Join us for the next MCRC Lecture with Professor Heidi Lyng, exploring how tumour hypoxia can affect cancer progression, treatment response and radiotherapy decisions. 📅 Thursday 23 July, 15:30–16:30 📍Oglesby Cancer Research Building lecture theatre 🔗 Book your free place: ow.ly/N9yS50Znl2r
011
Reposted by Sara Valpione 🌻
UK Research and Innovation @ukri.org · 21/07/2026
The UK Metascience Unit has launched the ‘National AI in Research’ Survey. We're looking for researchers across all disciplines and career stages to share their views on the use of AI in research. The survey will be published and used to inform national policy on AI in research.
smartsurvey.co.uk
National AI in Research Survey
Please take the time to complete our survey. Your feedback is important.
0613
Reposted by Sara Valpione 🌻
Itai Yanai @itaiyanai.bsky.social · 21/07/2026
Is science irrational? ..beauty is incredibly informative about which theories are right.. [but in] our official means of arguing with one another about which theories are right [..] is not allowed to appeal to beauty.. That's what I take to be strictly speaking irrational. –Michael Strevens
142
Reposted by Sara Valpione 🌻
Elizabeth McKenna @elizsmckenna.bsky.social · 21/07/2026
In case you missed this Cancer Discovery paper in the news last week: First-in-Human Testing of a Mutant KRAS Vaccine for Pancreatic Cancer Interception in High-Risk Cohorts - by Daniel Haldar, Amanda Huff, Michael Goggins, Elizabeth Jaffee, Neeha Zaidi, and colleagues @aacrjournals.bsky.social
0146
Reposted by Sara Valpione 🌻
Elizabeth McKenna @elizsmckenna.bsky.social · 21/07/2026
CDK8 Inhibition Induces Mediator Trapping and Impairment of the EWSR1-FLI1 Transcriptional Program in Ewing Sarcoma - by James McGinnis, Shuai Wang, David MacFadden, and colleagues doi.org/10.1158/2159...
doi.org
CDK8 inhibition induces Mediator trapping and impairment of the EWSR1::FLI1 transcriptional program in Ewing sarcoma.
Abstract. Ewing sarcoma is characterized by a chromosomal translocation resulting in the fusion protein EWSR1::FLI1. We utilize endogenous EWSR1::FLI1 target gene reporters in patient-derived cell lin...
041
Reposted by Sara Valpione 🌻
Elizabeth McKenna @elizsmckenna.bsky.social · 21/07/2026
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma - by Susu Zhang, Kathleen Engel, Corinne Linardic, Kim Stegmaier, and colleagues @danafarber.bsky.social @broadinstitute.org doi.org/10.1158/2159...
doi.org
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma
Abstract. Alveolar rhabdomyosarcoma (aRMS) is a fusion-driven pediatric cancer with poor survival and limited therapeutic options. To uncover novel vulnerabilities, we employed complex-based analysis ...
141
Reposted by Sara Valpione 🌻
Elizabeth McKenna @elizsmckenna.bsky.social · 21/07/2026
Now in Cancer Discovery: two studies showing that CDK8 inhibitors act by trapping Mediator on chromatin & that cancers w/driver oncogenes acting as dosage-sensitive transcription factors (e.g. aRMS, Ewing sarcoma) are vulnerable to impairment of transcriptional regulatory complex dynamics:
173
Reposted by Sara Valpione 🌻
British Society for Immunology @britsocimm.bsky.social · 21/07/2026
📢 Programme update! We're delighted to welcome Prof Adrian Hayday as the keynote speaker for #BSI26. His pioneering research has transformed our understanding of gamma delta (γδ) T cells & their role in cancer, inflammation & tissue immunity. Read more: vist.ly/5byyj
BSI Congress 2026 with keynote speaker Adrian Hayday, 30 November - 3 December 2026, SEC Glasgow.
084
Reposted by Sara Valpione 🌻
BSI Clinical Immunology Professional Network @bsi-cipn.bsky.social · 21/07/2026
What does research look like alongside a clinical career? #BSICIPN #ClinicalResearch Over the coming weeks, we'll be sharing a new interview series featuring professionals from across the clinical immunology community. The first interview with Dr Fatima Dhalla launches tomorrow! Keep an eye out 🙂
043